Meiji Seika Kaisha Ltd. Japan

www.meiji.co.jp

Meiji Seika is active the three areas of food pharmaceuticals and new business lines. Based on the main themes food and pharmaceuticals, Meiji Seika are providing products, services and information in the related fields of confectionery, food products, medicine, health, agricultural chemicals and veterinary medicines, and the environment.

In 1946 Meiji made their first surface culture of penicillin.

In 1950, Meiji Seika marketed Streptomycin and then went on to make rapid progress in aerobic fermentation techniques by using large tanks. In 1958, Meiji Seika achieved Japan's first production of an internationally accepted antibiotic with the development of Kanamycin by using their own technology. Since then, Meiji Seika, has launched high selling antibiotics, one after another including Dibekacin, Fosfomycin, Midecamycin acetate, Cefminox, Arbekacin, and Cefditoren pivoxil.